Drug intelligence / Profile preview

losartan or nebivolol

Development stage
Unknown
Administration
Oral, Intravenous
01

Overview

The input "losartan or nebivolol" refers to two distinct pharmaceutical drugs, losartan and nebivolol. Losartan is an angiotensin II receptor blocker (ARB) primarily used to treat hypertension, diabetic nephropathy, and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy. It works by blocking the binding of angiotensin II to the AT1 receptor, which leads to vasodilation, decreased aldosterone secretion, and a reduction in blood pressure. Nebivolol is a beta-blocker, specifically a beta-1 selective adrenergic receptor blocker, that also exhibits nitric oxide-mediated vasodilation. It is used for the treatment of hypertension and heart failure. Its mechanism involves selectively blocking beta-1 adrenergic receptors, thereby reducing heart rate and myocardial contractility, and promoting vasodilation through the release of nitric oxide.

02

Targets

AGTR1 (Angiotensin II Type-1 receptor)ADRB1 (β1)

Beyond the preview

Go deeper on losartan or nebivolol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on losartan or nebivolol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call